The purpose of this study is to learn if a study medication called semaglutide (known as Ozempic) improves blood sugar control in people treated with dialysis.
Thank you for your interest, but this study is not currently enrolling.
North Carolina (Statewide), Texas
Klara Klein
Medicine-Endocrinology
Clinical or Medical
Interventional
Chronic Conditions
Diabetes
Kidneys and Liver
Obesity
23-1060
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
